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           Apoptosis is an essential process in eliminating 
superfl  uous or potentially dangerous cells in 
multicellular organisms (  1  ). Dysregulation of 
this evolutionarily conserved mechanism could 
lead to cancer, autoimmunity, or degenerative 
disorders. Apoptosis plays an especially impor-
tant role in regulating and establishing the T cell 
repertoire during T cell development. Develop-
ing immature T cells or thymocytes are sub-
ject to selection based on the binding avidity 
between their TCR and self-peptide  –  MHC 
complexes. Thymocytes that strongly recognize 
self-peptide  –  MHC undergo apoptosis through 
a process termed negative selection, whereas a 
weak recognition of self-peptide  –  MHC results 
in survival and further development. Negative 
selection ensures that thymocytes leaving the 
thymus are tolerant to the host  ’  s own proteins 
and thus contributes to prevention of autoim-
munity. Mice with a mutation in   AIRE  , a gene 
essential for expression of   “  tissue-specifi  c  ”   anti-
gens in thymic antigen-presenting cells, exhibit 
severe autoimmunity due to the defective process 
of antigen presentation for negative selection (  2  ). 
The signal transduction pathways leading to 
negative selection in thymocytes are not fully 
understood. Previous work has implicated only 
a few molecules, including MINK, JNK, and 
p38 kinases as well as the downstream eff  ector 
molecules Bim, a Bcl-2 proapoptotic member, 
and the Nur77 family of transcription factors 
(  3, 4  ). Null mutation in   Bim   or expression of a 
dominant-negative Nur77 protein resulted in a 
partial rescue of cells destined to die through 
negative selection (  5  –  7  ). The molecular rela-
tionship between these pathways, however, is 
not clear, and how Nur77 causes thymocyte cell 
death remains to be elucidated. 
  Nur77 is an orphan nuclear steroid receptor 
that belongs to the steroid/thyroid hormone 
receptor superfamily (  4  ). The Nur77 family 
consists of Nur77, Nor-1, and Nurr1. In thy-
mocytes and T cells, expression of only Nur77 
and Nor-1 is induced in response to strong 
engagement of the TCR and correlates with 
apoptosis (  8  ). Although   Nur77      /        mice have 
no phenotype, redundancy with Nor-1 is the 
likely explanation (  8, 9  ). Overexpression of a 
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we used Western blot analysis with antibodies for either a 
nuclear-specifi  c protein lamin B or mitochondria-specifi  c 
proteins HSP-60 and cytochrome c. However, we found 
that pestle homogenization, a step described in all published 
fractionation protocols, led to rupture of mitochondria in 
these fragile thymocytes, resulting in impure cell fraction-
ation and very little intact mitochondria. Using a modifi  ed 
protocol involving no pestle homogenization, we have suc-
cessfully isolated fractions from thymocytes in a consistent 
manner. Thymocytes were either not stimulated or stimu-
lated with anti-CD3/CD28 for either 2 or 6 h to induce 
apoptosis. Fractions were then probed with antibodies spe-
cifi  c for either Nur77 or Nor-1. In addition to the nucleus, 
both Nur77 and Nor-1 could be found at the mitochondria 
in a stimulus-dependent manner (  Fig. 1 A  ).   Nur77 was found 
in the mitochondria fractions from thymocytes stimulated for 
either 2 or 6 h, whereas a strong Nor-1 signal was found in 
the 6-h time point. As expected, very little Nur77 or Nor-1 
was found in the nucleus or mitochondria fraction of unstim-
ulated thymocytes. Similar results were obtained with PMA/
ionomycin-stimulated thymocytes, which also induced cell 
death, although the kinetics of Nur77/Nor-1 appearance in 
mitochondria varied depending on the concentrations of 
PMA and ionomycin used (unpublished data). 
  To see if the mitochondria-specifi  c Nur77/Nor-1 signals 
are export dependent, we added leptomycin B, a nuclear ex-
port inhibitor (  21  ). Leptomycin B completely blocked the 
translocation of Nur77 and Nor-1 to mitochondria, whereas 
it had a minimal eff  ect on the Nor-1 levels in the nucleus. 
Although leptomycin B did decrease the levels of nuclear 
Nur77 to some extent, its eff  ect on Nur77 translocation to 
mitochondria is more dramatic and complete. Consistent with 
this notion, leptomycin B had a minimal eff  ect on Nur77 and 
Nor-1 transactivation activities in a luciferase reporter assay, 
affi   rming intact nuclear function of Nur77/Nor-1 (  Fig. 1 B  ). 
Thus, Nur77 and Nor-1 are transported to the thymic mito-
chondria from the nucleus after TCR-mediated stimulation. 
Interestingly, leptomycin B also signifi  cantly inhibited the 
apoptotic activities of anti-CD3/CD28 or PMA/ionomycin 
in thymocytes but not that of dexamethasone (  Fig. 1 C  ), sug-
gesting that a signifi  cant portion of TCR-mediated apoptotic 
activities occurs outside the nucleus. 
  To determine if Nur77 family proteins were capable of 
binding to Bcl-2, coimmunoprecipitation experiments were 
performed using either Nur77 or Nor-1  –  specifi  c antibodies, 
followed by Western blot analysis with the Bcl-2  –  specifi  c anti-
bodies. Because thymocytes contain very few mitochondria and 
also express very little Bcl-2, especially for nonstimulated thymo-
cytes, we used   lck-Bcl-2   transgenic mice (  22  ). Freshly isolated 
thymocytes were stimulated for 4 h with PMA/ionomycin. 
PMA/ionomycin treatment was used for this experiment 
because it stimulates higher levels of Nur77 and Nor-1 com-
pared with anti-CD3/CD28 treatment. The lysate obtained 
from PMA/ionomycin-treated thymocytes was immuno-
precipitated with rabbit IgG control, anti-Nur77, or anti  – 
Nor-1 antibodies. As shown in  Fig. 1 D , Bcl-2 was specifi  cally 
dominant-negative Nur77 protein, which blocks the activity 
of all family members, can inhibit apoptosis associated with 
negative selection (  6, 7  ). Conversely, constitutive expression 
of either Nur77 or Nor-1 but not Nurr1 in thymocytes leads 
to massive apoptosis (  9  ). Establishing Nur77  ’  s mode of action 
during negative selection has proven to be elusive so far. As a 
transcription factor, Nur77 regulates several downstream 
genes, including TRAIL, Fas ligand, and two genes with 
poorly characterized function, NDG1 and NDG2. NDG1 
can initiate apoptosis through caspase-8, and thus Nur77 
transcription might lead to caspase cleavage through the death 
receptor pathways or caspase-8 (  10  ). In addition, a mutant 
Nur77 with higher transcriptional activity causes more apop-
tosis in thymocytes than a mutant Nur77 that exhibits little 
transcriptional capability (  11  ). Thus, Nur77 transcriptional 
activity seems to correlate with its apoptotic function. How-
ever, a dominant-negative protein of FADD, which can si-
multaneously inhibit signaling from multiple death receptors, 
showed no eff  ect on negative selection (  12  ). Thus, it is possi-
ble that Nur77 initiates apoptosis through other mechanisms. 
Interestingly, Nur77 has been reported to be capable of trans-
locating from the nucleus to mitochondria in cancer cell lines 
(  13  –  17  ). At the mitochondria of cancer cell lines, Nur77  ’  s 
association with Bcl-2 at a linker region between the BH3 
and BH4 domains of Bcl-2 was reported to expose the Bcl-2 
BH3 domain that converts Bcl-2 into a proapoptotic mole-
cule (  14  ). Whether this is physiologically relevant or not 
is not clear. Most of the original experiments were done 
through overexpression of a Nur77 mutant lacking the DNA 
binding domain. In thymocytes, Nur77 was reported to lo-
calize mainly in the nucleus in one report (  18  ). However, 
thymocytes are known to be fragile, and cell fractionation 
studies of thymocytes are notoriously diffi   cult because they 
contain very little cytoplasm. Using an optimized fraction-
ation protocol, we report here that Nur77 and its family 
member Nor-1 are present in thymic mitochondria in an ex-
port-dependent fashion. We also present evidence that Nur77 
and Nor-1 associate with Bcl-2 in stimulated thymocytes. 
Exposure of the Bcl-2 BH3 domain was detected in in vitro 
anti-CD3/CD28 or PMA/ionomycin-stimulated thymo-
cytes and in two TCR transgenic models of negative selec-
tion. Based on these data, we present a simplifi  ed model of 
apoptosis during negative selection through the mitochon-
dria via Nur77/Nor-1/Bcl-2 and Bim. 
    RESULTS AND DISCUSSION   
  Nur77 family members are localized to the mitochondria 
and associate with Bcl-2 in stimulated thymocytes 
  In cancer cell lines, the conversion of Bcl-2 to a proapoptotic 
form by Nur77 was reported to be mediated by translocation 
of Nur77 from the nucleus to the mitochondria (  14  ). In thy-
mocytes, Nur77 could be detected easily in the nucleus. 
However, the mitochondria fraction was very diffi   cult to ob-
tain. We fi  rst performed cell fractionation with thymocytes 
using published protocols (  18  –  20  ). To monitor fractionation, JEM VOL. 205, May 12, 2008  1031
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CD28 or PMA/ionomycin-treated thymocytes. Thymocytes 
were cultured for various times with either PMA/ionomycin 
or anti-CD3/CD28, and then stained with antibodies spe-
cifi  c for CD4 and CD8 and intracellularly with antibodies 
specifi  c for the Bcl-2 BH3 domain. The Bcl-2 BH3 domain 
is usually buried within the folded Bcl-2 protein and unde-
tectable by the Bcl-2/BH3-specifi  c antibodies (  14, 24  ). 
Exposure of this domain correlates with the proapoptotic ac-
tivities of Bcl-2 (  14  ). We measured Bcl-2 BH3 exposure in 
various thymocyte populations. As expected, unstimulated 
thymocytes did not stain with the anti  –  Bcl-2/BH3 antibodies 
(  Fig. 2 A  , solid lines).   With 1.25   μ  g/ml PMA and 0.5   μ  M 
ionomycin or anti-CD3/CD28 stimulation, however, Bcl-2/
BH3 staining was clearly observed in 4- and 6-h  –  stimulated 
double positive (DP) but not single positive (SP) or double 
negative (DN) thymocytes (  Fig. 2, A and B  ). With a higher 
concentration of PMA/ionomycin (2.5   μ  g/ml PMA and 
0.5   μ  M ionomycin), Bcl-2/BH3 staining was seen as early as 
2 h after stimulation (not depicted). In contrast, intracellular 
coimmunoprecipitated with the Nur77 or Nor-1 antibodies, 
and not with the control rabbit IgG, indicating the inter-
action of Nur77 and Nor-1 with Bcl-2 under physiological 
conditions. Leptomycin B treatment effi   ciently  blocked 
the association of Nur77 and Nor-1 with Bcl-2 in PMA/
ionomycin-stimulated thymocytes, confi  rming that the asso-
ciation occurred outside the nucleus. The observation of Nor-1 
localization at the mitochondria, along with the protein  ’  s 
ability to bind to Bcl-2, is not surprising. It has been known 
that Nor-1 and Nur77 share redundancy in function and 
both exhibit   >  90% homology at the reported Bcl-2  –  interacting 
region, DC1 (  14  ). 
  The Bcl-2 BH3 domain is exposed in anti-CD3/CD28 
or PMA/ionomycin-stimulated thymocytes 
  In several cancer cell lines, association of Nur77 with Bcl-2 
in mitochondria leads to Bcl-2 conformation change and ex-
posure of its BH3 domain (  13  –  17, 23  ). We investigated 
whether this domain exposure also occurs in anti-CD3/
    Figure 1.         Nur77 and Nor-1 localize to the mitochondria and associate with Bcl-2 in anti-CD3/CD28 or PMA/ionomycin-treated thymo-
cytes  . (A) Nuclear and mitochondrial fractions of wild-type thymocytes cultured with 10   μ  g/ml anti-CD3 and 2   μ  g/ml anti-CD28 (plate-bound) were iso-
lated and blotted with anti-Nur77 and anti  –  Nor-1 antibodies. For fraction purity, the blot was also probed with antibodies for lamin B, HSP60, Bcl-2, and 
cytochrome c. (B) Transcriptional activity of Nur77 and Nor-1 was determined using a luciferase assay (as described in Materials and methods) on 293T 
cells transiently transfected with the indicated expression plasmids along with a Nur77/Nor-1  –  dependent luciferase reporter construct and renilla inter-
nal control construct. (C) The extent of apoptosis in wild-type thymocytes cultured with 10   μ  g/ml anti-CD3/2   μ  g/ml CD28 (plate-bound), 1.25 ng/ml 
PMA/0.5   μ  M ionomycin, or 0.5   μ  M dexamethasone (Dex) was assessed by annexin V staining. Apoptosis was normalized to the untreated controls. (D) Cell 
lysates from   lck-Bcl-2   thymocytes cultured with 2.5 ng/ml PMA/0.5   μ  M ionomycin were immunoprecipitated (IP) with anti  –  rabbit IgG (IP crtl), anti-
Nur77, and anti  –  Nor-1 antibodies, followed by blotting with an anti  –  Bcl-2 antibody. Results shown in A and D represent three to six independent experi-
ments. Data in B and C represent the mean   ±   SD of three independent experiments. Thymocytes were pretreated for 2 h with 20 nM leptomycin B (LMB) 
where indicated.     1032 BCL-2 AND NUR77 INTERACTION IN THYMOCYTES | Thompson and Winoto
stimulated DP thymocytes (  Fig. 2 D  ). We also showed that 
leptomycin B, which inhibits translocation of Nur77/Nor-1 
to mitochondria, completely blocked the Bcl-2/BH3 domain 
conversion in anti-CD3/CD28 and PMA/ionomycin-stim-
ulated DP thymocytes (  Fig. 2, B and D  ). 
  To confi  rm the fl  ow cytometric data further, we per-
formed coimmunoprecipitation studies with the Bcl-2/BH3-
specifi  c antibodies. Thymocytes from   lck-Bcl-2   transgenic 
mice were stimulated with PMA/ionomycin for 4 h in the 
absence or presence of leptomycin B. The immunoprecipi-
tates were then probed for the presence of Nur77, Bcl-2, or 
Nor-1. Consistent with the fl  ow data, we found Nur77 and 
Nor-1 solely in the Bcl-2/BH3 immunoprecipitates of stim-
ulated thymocytes (  Fig. 2 E  ). No Nur77 or Nor-1 could be 
detected in the Bcl-2/BH3 immunoprecipitates of leptomycin 
B  –  treated stimulated thymocytes. In addition, Bcl-2 could 
only be pulled down using these antibodies in apoptotic thy-
mocytes. No Bcl-2 was seen in the immunoprecipitates when 
staining with antibodies specifi  c for total Bcl-2 showed the 
same levels in all times, consistent with the notion that the 
Bcl-2/BH3 staining is dependent on the conformation change 
and not on an increase in the total levels of Bcl-2. The Bcl-2/
BH3 staining was specifi  c to the CD69  high   DP population 
of cells that had just received TCR stimulation (  Fig. 2 C  ). 
No staining was seen in PMA/ionomycin-stimulated   Bcl-
2      /        DP thymocytes, confi  rming the specifi  city of the anti-
bodies (  Fig. 2 C  ). Interestingly, Bcl-2/BH3 staining was still 
seen in   Nur77      /        DP thymocytes (  Fig. 2 C  ). This could be 
due to the redundant function of Nor-1, which we have shown 
is also capable of associating with Bcl-2 at the mitochondria. 
  As the MEK5  –  ERK5 pathway regulates both Nur77 
and Nor-1 transcription (  25  ), we used a high concentration 
of U0126, which can inhibit the ERK5 pathway in all cells 
(  26  ). Consistent with the MEK5  →  ERK5  →  Nur77/Nor-1  →
  Bcl-2/BH3 signal transduction pathway, U0126 blocked the 
Bcl-2/BH3 conformational change of PMA/ionomycin-
    Figure 2.         Bcl-2/BH3 exposure was observed in anti-CD3/CD28 and PMA/ionomycin-treated thymocytes.   (A) Bcl-2/BH3 and Bcl-2 expression of 
DP cells from thymocytes cultured for 2, 4, and 6 h with 1.25 ng/ml PMA/0.5   μ  M ionomycin. Solid lines represent untreated thymocytes, and dotted lines 
represent treated thymocytes. (B) Bcl-2/BH3 exposure of DP cells from thymocytes cultured for 2, 4, and 6 h with 10   μ  g/ml anti-CD3/2   μ  g/ml anti-CD28 
(plate-bound) and Bcl-2/BH3 exposure of DN and SP cells treated for 6 h. Here, the shaded area represents isotype control, dotted lines represent treated 
thymocytes, and solid lines represent treated thymocytes in the presence of leptomycin B. (C) Bcl-2/BH3 exposure of DP cells from   Nur77    /      and   Bcl-2    /     
thymocytes cultured for 4 h with 2.5 ng/ml PMA/0.5   μ  M ionomycin. Shaded area represents isotype control, solid lines represent untreated thymocytes, 
and dotted lines represent treated thymocytes. Bcl-2/BH3 expression of CD69  high   and  CD69 low   DP cells treated with 2.5 ng/ml PMA/0.5   μ  M ionomycin for 
4 h is also shown. The shaded area represents isotype control, the solid line represents CD69  low   DP cells, and the thick line represents CD69  high   DP  cells. 
(D) Pretreatment with 20 nM leptomycin B or 25   μ  M of the ERK5 inhibitor U0126 prevented exposure of the Bcl-2/BH3 domain in DP thymocytes stimulated 
for 4 h with PMA/ionomycin. Here, the shaded areas represent isotype control, dotted lines represent treated thymocytes, and solid lines represent PMA/
ionomycin-treated thymocytes in the presence of leptomycin B or U0126. (E) PMA/ionomycin (PMA/iono) -stimulated thymocytes from   lck-Bcl-2   mice 
were immunoprecipitated with anti-BH3 Bcl-2 antibodies or rabbit IgG, followed by blotting with antibodies specifi  c for Nur77, Bcl-2, or Nor-1. Leptomy-
cin (LMB) was added where indicated (+).     JEM VOL. 205, May 12, 2008  1033
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mice were injected intraperitoneally with PBS alone or with 
20 or 50 nmol of NP peptide. After 15h, thymocytes were 
analyzed by fl  ow cytometry for V    11, CD4, CD8, and Bcl-2/
BH3 expression. In PBS-injected F5 TCR transgenic mice, 
DP thymocytes that expressed V    11were negative for BH3 
exposure (  Fig. 3  ).   An injection of 20 or 50 nmol of NP pep-
tide resulted in a decrease in DP thymocytes, as reported pre-
viously (  27  ). DP cells undergoing selection showed high 
expression of the BH3-exposed form of Bcl-2 (  Fig. 3 A  ). 
Staining was specifi  c for CD69  high   DP cells, as CD69  low   DP 
cells and CD4 or CD8 SP thymocytes were all negative for 
Bcl-2/BH3 signals (  Fig. 3, B and C  ). 
  To see if the same results can be extended to another 
negative selection model, we analyzed the HY TCR trans-
genic mice. The HY TCR transgenic mice express a TCR 
that specifi  cally recognizes the HY peptide derived from the 
Y chromosome in the context of the class I MHC molecule 
we used lysates from either unstimulated or leptomycin B/
PMA/ionomycin-treated thymocytes (  Fig. 2 E  , lanes 4 and 6). 
Thus, exposure of the Bcl-2 BH3 domain is dependent on 
TCR-induced proteins (e.g., Nur77 and Nor-1) that are 
translocated out of the nucleus. 
  The Bcl-2 BH3 domain is exposed in apoptotic thymocytes 
from two TCR transgenic mouse models 
  To see if Nur77/Nor-1  –  mediated Bcl-2 BH3 conversion 
also occurs during negative selection, we examined two 
TCR transgenic mouse models: F5 and HY (  27, 28  ). In the 
F5 TCR transgenic model, the majority of thymocytes ex-
press a receptor containing V    4 and V    11 TCR segments 
specifi  c for the infl  uenza nucleocapsid protein (NP 366  –  374) 
in the context of H-2D  b  . Negative selection is induced by 
intraperitoneal injection of the NP peptide 366  –  374 (  27  ). To 
analyze Bcl-2/BH3 domain conversion, F5 TCR transgenic 
    Figure 3.         Flow cytometric analysis of CD4, CD8, Bcl-2/BH3, and Bcl-2 staining of thymocytes from F5 TCR transgenic mice.   (A)  Bcl-2/BH3 
and Bcl-2 expression of DP cells from F5 TCR transgenic mice 15 h after injection of PBS or 20 or 50 nmol of nucleocapsid peptide. Here, the shaded area 
represents isotype control, solid lines represent DP cells from PBS-injected mice, thick solid lines represent DP cells from mice injected with 20 nmol NP 
peptide, and dotted lines represent DP cells from mice injected with 50 nmol NP peptide. (B) Bcl-2/BH3 exposure was not observed in DN and SP cells 
from F5 TCR transgenic mice after injection of PBS or 20 or 50 nmol of nucleocapsid peptide. (C) Bcl-2/BH3 expression on CD69  high   and  CD69 low   DP  cells 
from a F5 TCR transgenic animal 10 h after injection with 50 nmol NP peptide. Here, the shaded area represents isotype control, the solid line represents 
CD69  low   DP cells, and the thick solid line represents CD69  high   DP cells. Five independent experiments have been done with similar results. All staining of F5 
TCR transgenic mice is on V   11 +   thymocytes.   1034 BCL-2 AND NUR77 INTERACTION IN THYMOCYTES | Thompson and Winoto
abolish Nur77  ’  s ability to export from the nucleus, as this re-
gion contains an export signal. Our data here are consistent 
with the notion that Nur77-induced cell death in thymocytes 
can be mediated by its translocation to the mitochondria 
where it binds to Bcl-2, converting the antiapoptotic mole-
cule to a proapoptotic molecule during negative selection. 
This is consistent with a recent datum showing translocation 
of Nur77 to mitochondria in ionomycin-treated thymocytes 
(  20  ). Although others have previously reported that Nur77 
resides solely in the nucleus of immature DP thymocytes 
(  18  ), the discrepancy is most likely due to the fact that thy-
mocytes are extremely fragile and their organelles can be 
lysed easily with even a brief sonication or pestle homogeni-
zation. In this study, we used a method with minimal manip-
ulations and simply lysed thymocytes in a hypotonic solution. 
This protocol allowed us to consistently detect Nur77 and 
Nor-1 in mitochondria in an activation- and nuclear export  –
  dependent fashion. 
  Our fi  ndings suggest that negative selection may work 
through two eff  ector molecules that converge at the mito-
chondria via their interaction with Bcl-2. While Bim antag-
onizes Bcl-2 (  1  ), Nur77 converts Bcl-2 to a killer form. This 
hypothesis could explain the disparity between the eff  ects of 
Bim defi  ciency and Bcl-2 overexpression on negative selec-
tion. Although negative selection is defective in   Bim      /        mice, 
it is only ineffi   ciently blocked by overexpression of Bcl-2 (  5, 
31, 32  ). Overexpression of Bcl-2 was suffi   cient to block most 
other Bim-mediated apoptosis (irradiation, glucocorticoid, 
and death by neglect) but was unable to effi   ciently inhibit 
negative selection to any signifi  cant degree. Induction of 
Nur77/Nor-1 in negatively selected thymocytes and their 
relocalization to mitochondria followed by association with 
Bcl-2 can lead Bcl-2 to promote instead of block apoptosis in 
negatively selecting thymocytes. Although expressed at low 
levels in DP thymocytes, Bcl-2 has been shown to be in-
duced during negative selection (  29  ). Thus, in the presence 
of Nur77, Bcl-2 is a proapoptotic protein. Together, Nur77 
and Bim converge at the mitochondria to initiate apoptosis 
during negative selection. Additional experimentation, in-
cluding that with transgenic mice, will be necessary to test 
and refi  ne this model further. 
  MATERIALS AND METHODS 
  Antibodies and reagents.     Ionomycin and phorbol myristate acetate were 
obtained from EMD. The nuclear export inhibitor leptomycin B, the ERK5 
inhibitor U0126, and dexamethasone were obtained from Sigma-Aldrich. 
The antibodies used in this study include anti  –  Bcl-2 BH3 (Abgent), anti  –
  mouse Bcl-2 (eBioscience), and anti-CD4, CD8, CD69, HY TCR, cyto-
chrome c, Nur77, and V    11 (all from BD Biosciences). The rabbit IgG 
antibody was purchased from Jackson ImmunoResearch Laboratories. Nor-1  –
  specifi  c rabbit antibodies were manufactured in-house (  9  ). The HSP 60 and 
lamin B antibodies were purchased from Santa Cruz Biotechnology, Inc. and 
Abcam, respectively. 
  Thymocyte culture.     4   ×   10  6  /ml thymocytes were cultured in RPMI 
1640, supplemented with 10% fetal calf serum, and stimulated with 1.25 or 
2.5 ng/ml PMA plus 0.5   μ  M ionomycin or 10   μ  g/ml plate-bound anti-CD3 
D  b   (  28  ). During thymic development, thymocytes from male 
but not female transgenic mice undergo massive apoptosis 
due to negative selection of transgenic DP cells that recog-
nize the male-specifi  c antigens in the thymus (  24  ). Staining 
of DP cells from female and male HY TCR transgenic mice 
showed the exposure of the Bcl-2/BH3 domain in male but 
not female DP thymocytes (  Fig. 4  ).   Although male trans-
genic animals expressed more Bcl-2 in all thymocyte popu-
lations, BH3 exposure was restricted to DP cells and was 
undetectable in DN, CD8 SP, or CD4 SP thymocytes (  Fig. 4  ). 
Thus, only negatively selecting cells in vivo expose the Bcl-2 
BH3 domain. 
  Negative selection is one of the most important pro-
cesses in thymocyte development. It is critical that potentially 
dangerous thymocytes are eliminated. Thus, in addition to 
up-regulating and/or activating proapoptotic proteins, anti-
apoptotic proteins must be eff  ectively inhibited. In various 
negative selection models, Nur77 and Bim have been consis-
tently found to be key regulators of thymocyte cell death 
(  29, 30  ). In contrast to Bim, the eff  ector mechanism of Nur77-
mediated apoptosis has yet to be clearly defi  ned. The tran-
scriptional activity of Nur77 was initially thought to be 
responsible for its apoptotic activity. This conclusion was 
based on characterization of transgenic mice expressing C-
terminal truncation variants of Nur77 in the thymus (  11  ), and 
evidence showing an N-terminal truncation of the transcrip-
tional activation domain abolishes Nur77-dependent apopto-
sis (  6, 7  ). However, C-terminally truncated Nur77 may also 
    Figure 4.         Flow cytometric analysis of CD4, CD8, Bcl-2/BH3, and 
Bcl-2 staining of thymocytes from HY TCR transgenic mice.   (A)  Bcl-
2/BH3 and Bcl-2 expression of DP cells from female and male HY TCR 
transgenic mice. The shaded area represents isotype control, solid lines 
represent female DP cells, and the dotted lines represent male DP cells. 
(B) Male HY TCR mice show no exposure of the BH3 domain of Bcl-2 in DN 
or SP cells. Five independent experiments have been done with similar re-
sults. All staining of HY TCR transgenic mice is on HY TCR  +   thymocytes.   JEM VOL. 205, May 12, 2008  1035
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